Breaking News, Trials & Filings

PTC Begins Phase II/III Trial of PTC299 in COVID-19

PTC299 has a novel dual-mechanism of action that has the potential to address high viral replication and uncontrolled inflammatory response.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters